SCHEMBL6537356

SCHEMBL6537356

O=[N+]([O-])c1cc(C(F)(F)F)cc2c(Cl)ccnc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.57
MEN1 O00255 6/20 0.57
KMT2A Q03164 6/20 0.57
TDP1 Q9NUW8 5/20 0.57
KDM4E B2RXH2 5/20 0.57
CYP3A4 P08684 3/20 0.54
HPGD P15428 1/20 0.54
ALOX15 P16050 1/20 0.54
TSHR P16473 1/20 0.54
HIF1A Q16665 1/20 0.54
TXNRD1 Q16881 1/20 0.54
TXNRD3 Q86VQ6 1/20 0.54
TXNRD2 Q9NNW7 1/20 0.54
MAPT P10636 6/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 3/20 0.46
PKM P14618 2/20 0.46
HTT P42858 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HSP90AA1 P07900 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538436 0.81 ALDH1A1 (0.61) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL6536891 0.81 KMT2A (0.65) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL6537736 0.78 MEN1 (0.61) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL29656845 0.76 NOS3 (0.37) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL23301410 0.76 NOS3 (0.37) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL6537370 0.75 SLC40A1 (0.44) ALDH1A1MEN1KMT2AKDM4ECYP3A4
SCHEMBL5445828 0.74 HSP90AA1 (0.62) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL22122559 0.74 PIM1 (0.49) ALDH1A1MEN1KMT2ATDP1CYP3A4
SCHEMBL317836 0.73 KMT2A (1.00) ALDH1A1MEN1KMT2ATDP1KDM4E
Chloralin SCHEMBL455937 0.71 CYP3A4 (1.00) ALDH1A1TDP1KDM4ECYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed